The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Perhaps one should learn 999,999 x 4 doesn't equal 999,999.
You should've explaned it then.
Apparently you missed my advice from 13:11 today about not being a dick.
How can you get to nearly 9k posts and not understand that??
Here's what the Level 2 order book looks like.
https://www.youtube.com/watch?v=mzbCA8kl-Xc&list=PL8EB9A6E55C64389D&t=166s
I assume he's saying there are 4 orders on there which add up to a total volume of 999,000 shares between them.
I'm not even sure that's really a delay. It looks just as likely that the 1st November start date was just pencilled in when they submitted it on the 28th October.
https://clinicaltrials.gov/ct2/history/NCT05605093?A=1&B=2&C=Side-by-Side#StudyPageTop
Fruitsnveg - "listen to many but trust no one."
That's terrible advice and I don't trust it.
Seriously though, better advice would be to ignore all opinions and to verify any facts (and their sources) for yourself. Also, try not to be a dick.
I think it's most likely they've got a new trial lined up, fwiw. Probably STRIVE.
But everything Tommy just listed is plausible too.
Manifesto - "You don't know the numbers either HSD do you? So what do you have to back up your view??"
No I don't. Nobody does. That's what backs up my view it MIGHT happen.
It's days like this (when a company announces some good news) that posters like you crawl out of the woodwork to try to encourage others to follow your self-serving advice.
Here's my advice: shove it.
You said that $402m was £0.5 billion. It's actually £330m.
You didn't even get basic maths right. Why would your opinion be worth more than anyone elses?
Manifesto - "So why as an informed investor would you sell out now for less than £1"
Plenty of people who bought before SPRINTER would be looking at a healthy profit at £1 a share. Others might just be willing to cut their losses, or cash-in at their break-even price so they can retire, pay off their mortgage, buy a holiday home.
Do you even know how much of the company is held by people who are in that group, or who invested at 20-30p? No, obviously not.
Magmanus thought it was sensible to round £330m up to £500m. So at the very least you might want to approach his posts with a bucketload of scepticism.
Manifesto - "Yes some would be happy at 50p but not enough to get a vote through."
How do you know that?
Also, what would be the required price to get it approved in your "expert" opinion?
I'm not one of them, by the way. I'd be totally against a takeover or joint venture as things currently stand.
That's a weird comment, Manifesto.
How could you honestly claim to know what other shareholders would regard as a fair price? There will be people who would be very happy with 50p a share.
Incidentally, I don't normally mention different shares on another share's forum. But anyone who's interested in drug development should take a look at C4XD if you haven't already. They do AI drug discovery and have just (today) announced their third out-licensed drug, this time to Astra Zeneca. Also, their CEO was recently the interim head of the covid vaccine task force.
I normally hate phrases like "This is a really exciting company", but in this case I think it's an accurate description.
Manifesto,
I know, we keep disagreeing over the same things. But one way or another we'll have a better idea in just a few months where things are heading.
Sorry, £330m.
$402m is £303m.
Paladin,
Tbh I think it's unlikely TFG/Polygon will put in a bid to takeover the company.
But I think it's more likely that TFG will than anybody else. And if a new, large-scale trial is finalized before February, I think the chances of a takeover will drop to around zero.